TP53 is also mutated mainly in HPV(−) HNSCC, but with a much lower rate in HPV(+) cancers, where the TP53 protein is inactivated instead by HPV E6 oncoprotein through constant binding and degradation of TP53 protein32. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.